SB 1188 automatically aligns Arizona's controlled substance scheduling with federal classifications for FDA-approved medications (excluding Schedule I drugs), meaning Arizona will adopt the same schedules as the U.S. Drug Enforcement Administration without requiring separate state action. This allows healthcare providers in Arizona to prescribe these medications as permitted under federal law, eliminating the need for the state pharmacy board to reclassify them. The bill directly affects the Arizona State Board of Pharmacy and medical professionals who prescribe or dispense controlled substances by simplifying scheduling requirements. It applies only to drugs approved by the FDA and scheduled by the federal government (other than Schedule I), ensuring consistency with federal regulations.
HB 2960 establishes a grant program to fund specialized veterans' courts in Arizona counties and municipalities. It creates a "veterans' treatment court fund" using state appropriations, providing money to local governments to set up courts that address veterans' justice-involved behavior through individualized treatment plans for issues like PTSD, substance abuse, and traumatic brain injury. The program requires grantees to report annually on participant demographics, recidivism, treatment use, and program outcomes, with the Attorney General compiling statewide data and recommendations for improvement. This directly affects veterans involved in the criminal justice system by connecting them to targeted support services rather than standard court processing.
SB 1630 establishes a new Arizona Medicaid program providing home and community-based services for adults with serious mental illness, replacing institutional care when possible. It sets eligibility based on clinical criteria (like recent hospitalizations, medication complexity, or safety risks) and income limits (300% of federal SSI), with options for a qualified income trust to meet financial requirements. Covered services include personal care, medication management, supervised community living, adult day health, and nonemergency transportation. The program requires federal approval by 2027 and aims to support individuals in community settings while avoiding psychiatric hospital or residential facility placement.
HB 4010 establishes a Board of Genetic Counselors in Arizona to license and regulate genetic counselors. The bill defines "genetic counseling" and requires practitioners to obtain a license from this new board, which will protect the public by setting standards for practice and handling disciplinary actions. The board will consist of five licensed genetic counselors, two public members, and two physician members who interact professionally with counselors. This law directly affects genetic counselors seeking to practice in Arizona and ensures they meet specific certification and conduct standards before providing services.
SB 1814 establishes a temporary study committee to examine Arizona's substance use disorder treatment system. The committee, composed of legislators, health officials, clinicians, and individuals with lived experience, will study treatment availability, gaps in care, regulatory loopholes, and workforce needs. It must report by December 31, 2027, with recommendations for evidence-based standards, oversight reforms, and funding strategies. The committee expires on June 30, 2028, and does not enact new laws.
SB 1214 restricts Arizona physicians from using stem cells or birth tissue derived from aborted fetuses or embryos for therapy. It allows non-FDA-approved stem cell or birth tissue therapies only for orthopedics, wound care, or pain management, provided the cells come from FDA-registered or certified facilities (like blood banks or tissue banks) and meet specific safety and viability standards. The bill requires physicians to disclose in advertising and obtain detailed informed consent stating the therapy isn't FDA-approved, and mandates facilities to provide full certification details to physicians. These provisions directly affect medical providers, clinics, and tissue suppliers offering such therapies in Arizona.
HB 2611 amends Arizona law to define specific rights for children in foster care or kinship foster care placements. The bill lists 27 concrete rights, including access to education, medical care, privacy, safety, and participation in care planning meetings, with additional transition-focused rights for youth aged 14+ (e.g., career planning, help obtaining IDs). It requires child welfare agencies to provide written information about these rights to children upon placement and to post them in foster homes. The law also establishes complaint channels for children to report rights violations to the department or ombudsman. This directly affects all children in Arizona foster or kinship care placements.
SB 1165 prohibits Arizona health insurance plans (including hospital service corporations and health care service organizations) from charging cost-sharing fees (like deductibles or copays) for diagnostic and supplemental breast exams starting January 1, 2027. Diagnostic exams cover evaluations of abnormalities found during screenings or other tests, while supplemental exams are risk-based screenings for individuals with dense breasts, family history, or other factors. The bill requires insurers to cover these exams without cost-sharing even before a high-deductible plan’s deductible is met, aligning with National Comprehensive Cancer Network guidelines. It directly affects insurance providers and beneficiaries seeking these specific breast cancer screening services.
SB 1162 clarifies oversight for Arizona health care institutions by requiring the state Department of Health Services to license and monitor these facilities for compliance with safety and quality standards. The bill prevents the Arizona Health Care Cost Containment System from duplicating the Department's monitoring role, mandating that the system accept the Department's compliance decisions. It also establishes two key complaint procedures: (1) allowing the Department to close complaints after an off-site review if facilities provide evidence of implemented fixes, and (2) requiring complaints about incidents older than 12 months to be automatically closed without investigation. This directly affects health care institutions (like hospitals and nursing homes) and streamlines complaint handling for the Department.
SB 1235 establishes Arizona's participation in the Emergency Medical Services (EMS) Licensure Interstate Compact. It allows licensed EMTs, AEMTs, and paramedics from Arizona (the "home state") to practice in other participating states ("remote states") without obtaining new licenses, provided Arizona meets specific standards like requiring the national NREMT exam for initial licensure and sharing adverse actions. The compact requires member states to verify competency, share license-related disciplinary information, and maintain systems for cross-state recognition. This directly affects Arizona-licensed EMS personnel seeking to work temporarily in other member states and state EMS authorities managing licensure verification.
